LPL Financial’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-6,763
| Closed | -$225K | – | 4668 |
|
|
2022
Q4 | $225K | Buy |
+6,763
| New | +$218K | ﹤0.01% | 3899 |
|
|
2022
Q3 | – | Sell |
-13,487
| Closed | -$410K | – | 4554 |
|
|
2022
Q2 | $410K | Buy |
13,487
+1,411
| +12% | +$38.2K | ﹤0.01% | 3376 |
|
|
2022
Q1 | $314K | Buy |
+12,076
| New | +$287K | ﹤0.01% | 3541 |
|
|
2020
Q3 | – | Sell |
-18,880
| Closed | -$440K | – | 3659 |
|
|
2020
Q2 | $440K | Sell |
18,880
-1,090
| -5% | -$15.8K | ﹤0.01% | 2513 |
|
|
2020
Q1 | $168K | Buy |
19,970
+330
| +2% | +$2.78K | ﹤0.01% | 2869 |
|
|
2019
Q4 | $192K | Sell |
19,640
-9,425
| -32% | -$88.5K | ﹤0.01% | 3114 |
|
|
2019
Q3 | $276K | Sell |
29,065
-1,300
| -4% | -$13.7K | ﹤0.01% | 2751 |
|
|
2019
Q2 | $361K | Buy |
30,365
+725
| +2% | +$8.73K | ﹤0.01% | 2551 |
|
|
2019
Q1 | $522K | Buy |
29,640
+7,381
| +33% | +$123K | ﹤0.01% | 2192 |
|
|
2018
Q4 | $386K | Buy |
22,259
+934
| +4% | +$15.9K | ﹤0.01% | 2260 |
|
|
2018
Q3 | $318K | Sell |
21,325
-489
| -2% | -$7.58K | ﹤0.01% | 2641 |
|
|
2018
Q2 | $347K | Buy |
21,814
+312
| +1% | +$4.65K | ﹤0.01% | 2513 |
|
|
2018
Q1 | $305K | Buy |
21,502
+4,196
| +24% | +$62.1K | ﹤0.01% | 2594 |
|
|
2017
Q4 | $242K | Buy |
17,306
+2,478
| +17% | +$36.3K | ﹤0.01% | 2665 |
|
|
2017
Q3 | $212K | Buy |
14,828
+6
| +0% | +$86 | ﹤0.01% | 2631 |
|
|
2017
Q2 | $233K | Buy |
14,822
+2,342
| +19% | +$33.7K | ﹤0.01% | 2477 |
|
|
2017
Q1 | $165K | Sell |
12,480
-2,577
| -17% | -$36K | ﹤0.01% | 2533 |
|
|
2016
Q4 | $269K | Buy |
15,057
+982
| +7% | +$17.3K | ﹤0.01% | 2260 |
|
|
2016
Q3 | $267K | Buy |
+14,075
| New | +$275K | ﹤0.01% | 2214 |
|
Other funds holding VIVO
LPL Financial's VIVO Position: Q1 2023 in Review
LPL Financial sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 6,763 shares — an estimated $225K sold.
LPL Financial first reported a position in VIVO in Q3 2016 and held it in 19 quarters. The position peaked at $522K in Q1 2019. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- LPL Financial reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- LPL Financial sold 6,763 Meridian Bioscience Inc shares in Q1 2023, an estimated $225K.
- LPL Financial first reported a position in Meridian Bioscience Inc in Q3 2016 and held it in 19 quarters.
- LPL Financial's Meridian Bioscience Inc position peaked at $522K in Q1 2019.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on LPL Financial's 13F filing for Q1 2023, filed 10 May 2023.